Aigen Investment Management LP Invests $35,000 in Cronos Group Inc. (NASDAQ:CRON)

Aigen Investment Management LP purchased a new position in shares of Cronos Group Inc. (NASDAQ:CRON) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 19,538 shares of the company’s stock, valued at approximately $35,000.

Several other institutional investors have also bought and sold shares of CRON. Tower Research Capital LLC TRC lifted its holdings in Cronos Group by 140.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company’s stock worth $28,000 after purchasing an additional 8,019 shares during the period. Zacks Investment Management acquired a new stake in Cronos Group in the fourth quarter worth about $38,000. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Cronos Group by 53.7% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 47,800 shares of the company’s stock worth $86,000 after purchasing an additional 16,700 shares during the period. Shay Capital LLC lifted its holdings in Cronos Group by 79.6% in the fourth quarter. Shay Capital LLC now owns 55,413 shares of the company’s stock worth $112,000 after purchasing an additional 24,563 shares during the period. Finally, Aquatic Capital Management LLC acquired a new stake in Cronos Group in the fourth quarter worth about $148,000. Institutional investors and hedge funds own 8.71% of the company’s stock.

Cronos Group Trading Down 6.0%

Shares of NASDAQ CRON opened at $2.37 on Friday. Cronos Group Inc. has a twelve month low of $1.60 and a twelve month high of $2.77. The company has a market capitalization of $907.80 million, a price-to-earnings ratio of 47.40 and a beta of 1.01. The firm has a 50-day moving average of $2.06 and a two-hundred day moving average of $1.96.

Cronos Group (NASDAQ:CRON) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.08). Cronos Group had a net margin of 14.19% and a negative return on equity of 3.78%. The business had revenue of $33.46 million during the quarter, compared to analyst estimates of $45.73 million. As a group, research analysts predict that Cronos Group Inc. will post -0.03 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded shares of Cronos Group from a “hold” rating to a “sell” rating in a report on Saturday, August 9th.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.